...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Great Presetation today

Very encouraging....especially for the enzalutamide/ZEN-3694 combo data shown in slides 17 and 18!

Here's the slide deck

3
bfw
Oct 17, 2017 07:16PM
4
Oct 18, 2017 06:20AM
5
Oct 18, 2017 02:17PM
4
Oct 18, 2017 04:27PM
4
Oct 18, 2017 06:11PM
3
Oct 19, 2017 09:40AM
5
Oct 19, 2017 10:45AM
1
Oct 19, 2017 02:51PM
4
Oct 19, 2017 07:22PM
2
Oct 20, 2017 02:04AM
3
Oct 20, 2017 10:35AM
2
Oct 21, 2017 11:36AM
3
Oct 23, 2017 12:27PM
3
Oct 24, 2017 02:27AM
4
Oct 24, 2017 01:39PM
Share
New Message
Please login to post a reply